These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26109200)

  • 61. Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate.
    Andronesi OC; Arrillaga-Romany IC; Ly KI; Bogner W; Ratai EM; Reitz K; Iafrate AJ; Dietrich J; Gerstner ER; Chi AS; Rosen BR; Wen PY; Cahill DP; Batchelor TT
    Nat Commun; 2018 Apr; 9(1):1474. PubMed ID: 29662077
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IDH1 mutation promotes proliferation and migration of glioma cells via EMT induction.
    Lu J; Li D; Zeng Y; Wang H; Feng W; Qi S; Yu L
    J BUON; 2019; 24(6):2458-2464. PubMed ID: 31983120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model.
    Machida Y; Nakagawa M; Matsunaga H; Yamaguchi M; Ogawara Y; Shima Y; Yamagata K; Katsumoto T; Hattori A; Itoh M; Seki T; Nishiya Y; Nakamura K; Suzuki K; Imaoka T; Baba D; Suzuki M; Sampetrean O; Saya H; Ichimura K; Kitabayashi I
    Mol Cancer Ther; 2020 Feb; 19(2):375-383. PubMed ID: 31727689
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chemokine receptor CXCR7 is an independent prognostic biomarker in glioblastoma.
    Deng L; Zheng W; Dong X; Liu J; Zhu C; Lu D; Zhang J; Song L; Wang Y; Deng D
    Cancer Biomark; 2017 Jul; 20(1):1-6. PubMed ID: 28759950
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver.
    Guillemot E; Karimdjee-Soilihi B; Pradelli E; Benchetrit M; Goguet-Surmenian E; Millet MA; Larbret F; Michiels JF; Birnbaum D; Alemanno P; Schmid-Antomarchi H; Schmid-Alliana A
    Br J Cancer; 2012 Dec; 107(12):1944-9. PubMed ID: 23169289
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genotype-targeted local therapy of glioma.
    Shankar GM; Kirtane AR; Miller JJ; Mazdiyasni H; Rogner J; Tai T; Williams EA; Higuchi F; Juratli TA; Tateishi K; Koerner MVA; Tummala SS; Fink AL; Penson T; Schmidt SP; Wojtkiewicz GR; Baig A; Francis JM; Rinne ML; Batten JM; Batchelor TT; Brastianos PK; Curry WT; Barker FG; Jordan JT; Iafrate AJ; Chi AS; Lennerz JK; Meyerson M; Langer R; Wakimoto H; Traverso G; Cahill DP
    Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8388-E8394. PubMed ID: 30082399
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism.
    Mir Seyed Nazari P; Riedl J; Preusser M; Posch F; Thaler J; Marosi C; Birner P; Ricken G; Hainfellner JA; Pabinger I; Ay C
    J Thromb Haemost; 2018 Jun; 16(6):1121-1127. PubMed ID: 29676036
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma.
    Yanagiya M; Dawood RIH; Maishi N; Hida Y; Torii C; Annan DA; Kikuchi H; Yanagawa Matsuda A; Kitamura T; Ohiro Y; Shindoh M; Tanaka S; Kitagawa Y; Hida K
    Pathol Int; 2021 Jun; 71(6):383-391. PubMed ID: 33783897
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
    Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
    Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CXCR7 silencing inhibits the migration and invasion of human tumor endothelial cells derived from hepatocellular carcinoma by suppressing STAT3.
    Wu Y; Tian L; Xu Y; Zhang M; Xiang S; Zhao J; Wang Z
    Mol Med Rep; 2018 Aug; 18(2):1644-1650. PubMed ID: 29901083
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Overexpression of high mobility group box 1 (HMGB1) has no correlation with the prognosis in glioma.
    Jia L; Song Y; Song H; Wang G; Fan W; Li X; Zheng H; Yao A
    Biomark Med; 2019 Jul; 13(10):851-863. PubMed ID: 31241346
    [No Abstract]   [Full Text] [Related]  

  • 73. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.
    Kucharzewska P; Christianson HC; Welch JE; Svensson KJ; Fredlund E; Ringnér M; Mörgelin M; Bourseau-Guilmain E; Bengzon J; Belting M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7312-7. PubMed ID: 23589885
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma.
    Chen P; Zhao D; Li J; Liang X; Li J; Chang A; Henry VK; Lan Z; Spring DJ; Rao G; Wang YA; DePinho RA
    Cancer Cell; 2019 Jun; 35(6):868-884.e6. PubMed ID: 31185211
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SDF1/CXCR7 Signaling Axis Participates in Angiogenesis in Degenerated Discs via the PI3K/AKT Pathway.
    Zhang H; Wang P; Zhang X; Zhao W; Ren H; Hu Z
    DNA Cell Biol; 2019 May; 38(5):457-467. PubMed ID: 30864829
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.
    Monnier J; Boissan M; L'Helgoualc'h A; Lacombe ML; Turlin B; Zucman-Rossi J; Théret N; Piquet-Pellorce C; Samson M
    Eur J Cancer; 2012 Jan; 48(1):138-48. PubMed ID: 21778049
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion.
    Han M; Xu R; Wang S; Yang N; Ni S; Zhang Q; Xu Y; Zhang X; Zhang C; Wei Y; Ji J; Huang B; Zhang D; Chen A; Li W; Bjerkvig R; Li X; Wang J
    Neoplasia; 2018 Jun; 20(6):543-554. PubMed ID: 29730475
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
    Chen J; Hou C; Wang P; Yang Y; Zhou D
    World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High expression of CXCR4 and CXCR7 predicts poor survival in gallbladder cancer.
    Yao X; Zhou L; Han S; Chen Y
    J Int Med Res; 2011; 39(4):1253-64. PubMed ID: 21986127
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma.
    Wang X; Yang Q; Liu N; Bian Q; Gao M; Hou X
    Pathol Oncol Res; 2021; 27():1609825. PubMed ID: 34629960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.